Macular Degeneration Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are able and willing to attend all required study visits
• People who are able and willing to sign a consent form and follow the study instructions
• People who are able and willing to have eye imaging performed
• Adults aged 18 years or older
• People who have no abnormalities in the central area of the retina (the macula) — Group A
• People who have certain changes or abnormalities in the central area of the retina (the macula), such as changes at the boundary between the eye's gel and retina, fluid pockets within or beneath the retina, damage to specific retinal layers, or changes to the retinal pigment layer — Group B

Who may not be able to join:

• People who are unable to complete the required tests
• People who are unable to give consent or follow the study instructions
• People who have difficulty keeping their eye still enough to allow acceptable retinal scans to be taken
• People who have received a Visudyne (verteporfin) injection in the study eye within the last 48 hours
• People who have used Pilocarpine or Vuity eye drops in the study eye within the last 24 hours
• People who have significant cloudiness in the eye that prevents a clear view of the retina
• People who have vitreous floaters (small shapes drifting in the field of vision) that prevent acceptable scans from being taken

Important: Always verify eligibility with the trial site directly before applying.